BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17420769)

  • 1. Mathematical models of cytotoxic T-lymphocyte killing.
    Regoes RR; Yates A; Antia R
    Immunol Cell Biol; 2007 Jun; 85(4):274-9. PubMed ID: 17420769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo.
    Halle S; Halle O; Förster R
    Trends Immunol; 2017 Jun; 38(6):432-443. PubMed ID: 28499492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-dimensional organotypic assay to measure target cell killing by cytotoxic T lymphocytes.
    Weigelin B; Friedl P
    Biochem Pharmacol; 2010 Dec; 80(12):2087-91. PubMed ID: 20849829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of cell-mediated cytotoxicity at the single cell level. VIII. Kinetics of lysis of target cells bound by more than one cytotoxic T lymphocyte.
    Perelson AS; Macken CA; Grimm EA; Roos LS; Bonavida B
    J Immunol; 1984 May; 132(5):2190-8. PubMed ID: 6609191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do mathematical models tell us about killing rates during HIV-1 infection?
    Gadhamsetty S; Beltman JB; de Boer RJ
    Immunol Lett; 2015 Nov; 168(1):1-6. PubMed ID: 26279491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating CTL mediated killing with a 3D cellular automaton.
    Graw F; Regoes RR
    PLoS Comput Biol; 2009 Aug; 5(8):e1000466. PubMed ID: 19696876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloned cytotoxic T lymphocytes as target cells. II. Polarity of lysis revisited.
    Gorman K; Liu CC; Blakely A; Young JD; Torbett BE; Clark WR
    J Immunol; 1988 Oct; 141(7):2211-5. PubMed ID: 3262651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BLT esterase activity as an alternative to chromium release in cytotoxic T cell assays.
    Suhrbier A; Fernan A; Burrows SR; Saul A; Moss DJ
    J Immunol Methods; 1991 Dec; 145(1-2):43-53. PubMed ID: 1722495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity.
    Halle S; Keyser KA; Stahl FR; Busche A; Marquardt A; Zheng X; Galla M; Heissmeyer V; Heller K; Boelter J; Wagner K; Bischoff Y; Martens R; Braun A; Werth K; Uvarovskii A; Kempf H; Meyer-Hermann M; Arens R; Kremer M; Sutter G; Messerle M; Förster R
    Immunity; 2016 Feb; 44(2):233-45. PubMed ID: 26872694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing.
    Burrows SR; Suhrbier A; Khanna R; Moss DJ
    Immunology; 1992 May; 76(1):174-5. PubMed ID: 1378424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A general functional response of cytotoxic T lymphocyte-mediated killing of target cells.
    Gadhamsetty S; Marée AF; Beltman JB; de Boer RJ
    Biophys J; 2014 Apr; 106(8):1780-91. PubMed ID: 24739177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.
    Bennett MS; Ng HL; Dagarag M; Ali A; Yang OO
    J Virol; 2007 May; 81(10):4973-80. PubMed ID: 17329324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
    Gadhamsetty S; Coorens T; de Boer RJ
    J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
    van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
    Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cell biology of CTL killing.
    Griffiths GM
    Curr Opin Immunol; 1995 Jun; 7(3):343-8. PubMed ID: 7546398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the antiviral activity of HIV-1-specific cytotoxic T lymphocytes.
    Yang OO
    Methods Mol Biol; 2009; 485():407-15. PubMed ID: 19020840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic assay of cytotoxic T lymphocyte clones. II. Comparison of primary and secondary responses and lectin-dependent cytotoxicity.
    Jenski LJ
    J Immunol Methods; 1989 Feb; 117(2):191-8. PubMed ID: 2784154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial heterogeneity and peptide availability determine CTL killing efficiency in vivo.
    Hogan T; Kadolsky U; Tung S; Seddon B; Yates A
    PLoS Comput Biol; 2014 Sep; 10(9):e1003805. PubMed ID: 25233372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.